Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
195 hedge funds and large institutions have $2.79B invested in Medicines Co in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 79 increasing their positions, 63 reducing their positions, and 31 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 63
0% less call options, than puts
Call options by funds: $55M | Put options by funds: $55.1M
3% less funds holding
Funds holding: 201 → 195 (-6)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
12% less capital invested
Capital invested by funds: $3.16B → $2.79B (-$367M)
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$34.4M |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$33.6M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$27.5M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$15.4M |
| 5 |
PA
Pinnacle Associates
New York
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$75.5M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$35.2M |
| 3 |
Jennison Associates
New York
|
-$31.4M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$26.4M |
| 5 |
AWG
Alpha Wave Global
New York
|
-$24.2M |
MDCO Hedge Fund Activity: Q4 2016 in Review
195 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2016, worth a combined $2.79B — down 12% from $3.16B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of MDCO and 27 opened new positions — a net loss of 4 holders — while 63 trimmed existing stakes and 79 added.
The largest buyer was PFM Health Sciences, adding an estimated $34.4M. The largest seller was Camber Capital Management, exiting entirely with an estimated $75.5M sold.
- 195 institutional investors held Medicines Co (MDCO) as of Q4 2016, down from 201 in Q3 2016.
- Funds reported $2.79B of Medicines Co stock for Q4 2016, down 12% quarter-over-quarter.
- 27 funds opened new Medicines Co positions in Q4 2016 and 31 closed out, a net change of -4 holders.
- The largest Medicines Co buyer in Q4 2016 was PFM Health Sciences, an estimated $34.4M added.
- The largest Medicines Co seller in Q4 2016 was Camber Capital Management, an estimated $75.5M sold.
Based on aggregated 13F filings for Q4 2016.